Brief: S2Medical Announces Positive Results Of Peptides Tests
Jan 3 (Reuters) - S2Medical AB S2ME.ST :
* SAID ON MONDAY SCIENTISTS FROM HEALIX-PROJECT EVALUATED
ANTIMICROBIAL EFFECT FROM PEPTIDE TECHNOLOGY THAT COMPANY
ACQUIRED
* NEW RESULTS FROM IN VITRO STUDY SHOW SUBSTANTIALLY
POSITIVE
OUTCOME
Source text for Eikon: urn:newsml:reuters.com:*:nWkr79qQdB
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on S2Medical AB (publ)
See all newsBrief: Eyracure Company Part-owned By S2Medical Files For Bankruptcy
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries